Skip to content
WHO WE ARE
Team
Heritage
Impact
WHAT WE DO
Investment Strategies
Buyouts
Growth
Hospitality
Portfolio
News & Insights
INVESTORS
Open Funds
Portal
CONTACTS
Contact
Feedback
WHO WE ARE
Team
Heritage
Impact
WHAT WE DO
Investment Strategies
Buyouts
Growth
Hospitality
Portfolio
News & Insights
INVESTORS
Open Funds
Portal
CONTACTS
Contact
Feedback
Portocanna
Medical Canábis
EGF II | EGF III
Invested In
2023
Divested In
–
Investment Rationale
Portocanna aims to be one of the main medical-pharmaceutical cannabis processors in Europe.
Strategy
Development of new pharmaceutical formulas applicable to the processing of cannabis plant and oil under EU-GMP conditions.
Company website
arrow_b
Back to Portfolio
Previous
PlaySight
Next
Powervia
